Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
roche
biotech
life sciences
national blog main
national top stories
boston
boston blog main
boston top stories
deals
europe top stories
fda
genentech
atea pharmaceuticals
billy dunn
biogen
biopharma
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
coronavirus
covid-19
daniel o'day
drug prices
drug pricing
duchenne
europe blog main
evrysdi
foundation medicine
foundationone cdx
foundationone heme
gene therapy
ionis pharmaceuticals
licensing
m&a
muscular dystrophy
national
new york blog main
new york top stories
What
medicine
4
×
roche
4
×
billion
deal
drug
fda
new
oral
recently
swiss
therapy
acquire
agreed
announced
antiviral
approval
approved
atea
atrophy
betting
big
biopharma
broad
confidence
coronavirus
cure
currently
daily
developme
didn’t
duchenne
evrysdi
far
foundation
friday
gain
gene
genentech
giant
green
Language
unset
Current search:
roche
×
medicine
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine